IDEXX Laboratories Inc

NASDAQ IDXX

Download Data

IDEXX Laboratories Inc Current Assets to Total Assets Ratio 2 year CAGR for the year ending December 31, 2023: 8.16%

IDEXX Laboratories Inc Current Assets to Total Assets Ratio 2 year CAGR is 8.16% for the year ending December 31, 2023, a 217.34% change year over year. The current assets to total assets ratio measures the proportion of a company's current assets in relation to its total assets. It is calculated by dividing current assets by total assets. This ratio indicates the percentage of a company's total assets that are in the form of current assets, such as cash, receivables, and inventory. It provides insights into the company's liquidity and the extent to which its assets are readily convertible to cash in the short term. CAGR, or the Compound Annual Growth Rate, quantifies the mean annual growth rate of an investment or financial metric over a specified time span, considering the influence of compounding. It is instrumental in determining the true annualized return on an investment.
  • IDEXX Laboratories Inc Current Assets to Total Assets Ratio for the year ending December 31, 2022 was 0.40, a 2.27% change year over year.
  • IDEXX Laboratories Inc Current Assets to Total Assets Ratio for the year ending December 31, 2021 was 0.39, a -15.34% change year over year.
  • IDEXX Laboratories Inc Current Assets to Total Assets Ratio for the year ending December 31, 2020 was 0.46, a 24.88% change year over year.
  • IDEXX Laboratories Inc Current Assets to Total Assets Ratio for the year ending December 31, 2019 was 0.37, a -12.84% change year over year.
NASDAQ: IDXX

IDEXX Laboratories Inc

CEO Mr. Jonathan J. Mazelsky
IPO Date June 21, 1991
Location United States
Headquarters One IDEXX Drive, Westbrook, ME, United States, 04092
Employees 11,000
Sector Healthcare
Industry Diagnostics & research
Description

IDEXX Laboratories, Inc. develops, manufactures, and distributes products primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets in Africa, the Asia Pacific, Canada, Europe, Latin America, and internationally. The company operates through three segments: Companion Animal Group; Water Quality Products; and Livestock, Poultry and Dairy. It also provides point-of-care veterinary diagnostic products, including instruments, consumables, and rapid assay test kits; veterinary reference laboratory diagnostic and consulting services; practice management and diagnostic imaging systems and services for veterinarians; and health monitoring, biological materials testing, and laboratory diagnostic instruments, and services for biomedical research community. In addition, the company offers diagnostic and health-monitoring products for livestock, poultry, and dairy; products that test water for various microbiological contaminants; point-of-care electrolytes and blood gas analyzers; in-clinic chemistry, blood and urine chemistry, hematology, immunoassay, urinalysis, and coagulation analyzers; and SNAP rapid assays test kits. Further, it provides Colilert, Colilert-18, and Colisure tests, which detect the presence of total coliforms and E. coli in water; Enterolert, Pseudalert, Filta-Max and Filta-Max xpress, Legiolert, and Quanti-Tray products; and veterinary software and services for independent veterinary clinics and corporate groups. Additionally, the company offers human medical point-of-care products and laboratory diagnostics services. The company markets its products through marketing, customer service, sales, and technical service groups, as well as through independent distributors and other resellers. IDEXX Laboratories, Inc. was incorporated in 1983 and is headquartered in Westbrook, Maine.

Similar companies

WAT

Waters Corporation

NA

NA

CRL

Charles River Laboratories

NA

NA

RVTY

Revvity Inc.

NA

NA

A

Agilent Technologies Inc

NA

NA

DHR

Danaher Corporation

NA

NA

TWST

Twist Bioscience Corp

NA

NA

ICLR

ICON PLC

NA

NA

StockViz Staff

September 19, 2024

Any question? Send us an email